海角社区

Feature Channels: Biotech

Filters close
Released: 7-Feb-2025 8:00 PM EST
Texas Tech Lab Plays Key Role in Potential New Pathway to Fight Viruses
Texas Tech University

Professor David Ray鈥檚 laboratory in the Department of Biological Sciences helped identify genetic components in bats that provide insight into their immune systems.

access_time Embargo lifts in 2 days
This news release is embargoed until 10-Feb-2025 11:00 AM EST Released to reporters: 7-Feb-2025 7:40 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 10-Feb-2025 11:00 AM EST The 海角社区 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

海角社区: Co-located Cell Types Help Drive Aggressive Brain Tumors
Released: 7-Feb-2025 6:15 PM EST
Co-located Cell Types Help Drive Aggressive Brain Tumors
Johns Hopkins Medicine

Credit: Adobe Stock A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the聽Johns Hopkins Kimmel Cancer Center聽Bloomberg~Kimmel Institute for Cancer Immunotherapy聽and the聽Johns Hopkins University School of Medicine.

海角社区: AI Accelerates the Search for New Tuberculosis Drug Targets
Released: 6-Feb-2025 8:25 PM EST
AI Accelerates the Search for New Tuberculosis Drug Targets
University of California San Diego

As one of the largest tuberculosis outbreaks in the U.S. unfolds in Kansas, UC San Diego researchers and their colleagues have published research describing the use of artificial intelligence tools to screen for new antimicrobial candidates to treat the disease.

海角社区: 1920_dsc-0046.jpg?10000
Released: 6-Feb-2025 8:00 PM EST
Heart Transplant No. 2 Gives Destany Another Chance
Cedars-Sinai

When life gets bleak for Destany Epps-Manuel, 36, she knows the only way to go is forward. That鈥檚 what she鈥檚 been doing since she was 22, when she was diagnosed with dilated cardiomyopathy, a rare disease that causes the heart muscle to weaken and, eventually, stop pumping blood.

海角社区: A New Way to Detect Inflammation
Released: 6-Feb-2025 7:35 PM EST
A New Way to Detect Inflammation
Case Western Reserve University

Nearly every disease has an inflammatory component, but blood tests can鈥檛 pinpoint inflammation in specific organs or tissues in the human body.

Released: 6-Feb-2025 10:25 AM EST
OmicsFootPrint: La herramienta de IA de Mayo Clinic ofrece una nueva forma de visualizar enfermedades
Mayo Clinic

Investigadores de Mayo Clinic han sido pioneros en una herramienta de inteligencia artificial (IA) llamada OmicsFootPrint, que ayuda a convertir grandes cantidades de datos biol贸gicos complejos en im谩genes circulares bidimensionales. Los detalles de la herramienta se publicaron en un estudio en Nucleic Acids Research.

Released: 6-Feb-2025 9:30 AM EST
OmicsFootPrint: Ferramenta de IA da Mayo Clinic oferece uma nova forma de visualizar doen莽as
Mayo Clinic

Pesquisadores da Mayo Clinic foram pioneiros em uma ferramenta de intelig锚ncia artificial (IA) chamada OmicsFootPrint, que ajuda a converter grandes quantidades de dados biol贸gicos complexos em imagens circulares bidimensionais. Os detalhes da ferramenta foram publicados em um estudo na Nucleic Acids Research.

Released: 6-Feb-2025 9:20 AM EST
OmicsFootPrint: Mayo Clinic鈥檚 AI Tool Offers a New Way to Visualize Disease
Mayo Clinic

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool are published in a study in Nucleic Acids Research.

海角社区: Tackling Infections in Pediatric HSCT: A Risk-Adapted Approach
Released: 6-Feb-2025 8:00 AM EST
Tackling Infections in Pediatric HSCT: A Risk-Adapted Approach
Chinese Academy of Sciences

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with pediatric allogeneic hematopoietic stem cell transplantation (HSCT). The research identifies key risk factors that influence infection timelines and outcomes, offering a pathway toward more effective, personalized prevention strategies.

Released: 6-Feb-2025 12:30 AM EST
兀賵賲賷賰爻 賮賵鬲亘乇賳鬲: 兀丿丕丞 匕賰丕亍 丕氐胤賳丕毓賷 賲賳 賲丕賷賵 賰賱賷賳賰 鬲賵賮乇 胤乇賷賯丞 噩丿賷丿丞 賱鬲氐賵乇 丕賱賲乇囟
Mayo Clinic

乇賵鬲卮爻鬲乇貙 賵賱丕賷丞 賲賷賳賷爻賵鬲丕 鈥 丕亘鬲賰乇 亘丕丨孬賵 賲丕賷賵 賰賱賷賳賰 兀丿丕丞 匕賰丕亍 丕氐胤賳丕毓賷貙 鬲購爻賲賶 兀賵賲賷賰爻 賮賵鬲亘乇賳鬲 (OmicsFootPrint)貙 賱賱賲爻丕毓丿丞 賮賷 鬲丨賵賷賱 賰賲賷丕鬲 賴丕卅賱丞 賲賳 丕賱亘賷丕賳丕鬲 丕賱亘賷賵賱賵噩賷丞 丕賱賲毓賯丿丞 廿賱賶 氐賵乇 丿丕卅乇賷丞 孬賳丕卅賷丞 丕賱兀亘毓丕丿. 匕購賰乇鬲 鬲賮丕氐賷賱 丕賱兀丿丕丞 賮賷 丿乇丕爻丞 賳購卮乇鬲 賮賷 賲噩賱丞 "兀亘丨丕孬 丕賱兀丨賲丕囟 丕賱賳賵賵賷丞" (Nucleic Acids Research).

Released: 5-Feb-2025 7:00 PM EST
Nasal COVID-19 Vaccine Based on WashU Technology to Enter U.S. Clinical Trials
Washington University in St. Louis

A nasal vaccine for COVID-19 鈥 based on technology developed at Washington University in St. Louis 鈥 is poised to enter a phase 1 clinical trial in the U.S.

4-Feb-2025 9:00 PM EST
AI Tool Helps Find Life-Saving Medicine for Rare Disease
Perelman School of Medicine at the University of Pennsylvania

Set to enter hospice care, a patient with idiopathic multicentric Castleman鈥檚 disease is now in remission after treatment with a medication identified by an AI-guided analysis

海角社区: 鈥楪ated鈥 CAR T-Cells Are Effective Against AML鈥擶ith Less Toxicity
Released: 5-Feb-2025 12:00 PM EST
鈥楪ated鈥 CAR T-Cells Are Effective Against AML鈥擶ith Less Toxicity
Children's Hospital Los Angeles

Over the past decade, chimeric antigen receptor (CAR) T-cell therapy has revolutionized treatment for children with B-cell acute lymphoblastic leukemia (ALL). But unfortunately, CAR T-cells have been far less effective for another blood cancer: acute myeloid leukemia (AML).

海角社区: Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer
Released: 5-Feb-2025 11:30 AM EST
Cancer Vaccine Shows Promise for Patients with Stage III and IV Kidney Cancer
Dana-Farber Cancer Institute

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

Released: 5-Feb-2025 11:25 AM EST
Personalized Therapeutic Vaccine 鈥楽teers鈥 the Immune System to Fight Kidney Cancer
Yale Cancer Center/Smilow Cancer Hospital

Personalized cancer vaccines (PCVs) train the body鈥檚 immune system to recognize and destroy a threat. In this trial, all nine patients who received multiple doses of the vaccine had an immune response within a three-week period and cancer fighting T cells remained elevated for the duration of the study and for years afterward.

access_time Embargo lifts in 2 days
This news release is embargoed until 12-Feb-2025 11:00 AM EST Released to reporters: 5-Feb-2025 11:00 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 12-Feb-2025 11:00 AM EST The 海角社区 PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 5-Feb-2025 9:35 AM EST
Children鈥檚 National Hospital and Virginia Tech Expand Research Partnership to Advance Pediatric Health
Virginia Tech

Children鈥檚 National, ranked among the nation鈥檚 top pediatric hospitals, and Virginia Tech, a nationally leading academic research university, aim to deliver transformative advancements to enhance outcomes for children facing devastating cancer diagnoses.



close
2.8053